Avtor/Urednik | Krisch, I | |
Naslov | Vrednotenje antipsihotičnega potenciala dveh novosintetiziranih derivatov ergolina pri poskusnih živalih | |
Tip | monografija | |
Kraj izdaje | Ljubljana | |
Založnik | Medicinska fakulteta | |
Leto izdaje | 1995 | |
Obseg | str. 53 | |
Jezik | slo | |
Abstrakt | The pharmacological properties of LEK-8829: 9,10-didehydro-N-methyl-N-(2-propynyl)-6-methyl-8beta-aminomethylergoline and LEK-8841: 9,10-didehydro-N-methyl-N-(2-propynyl)-2-bromo-6-methylergoline-8betha-carboxamide, new ergoline derivatives, were compared with those of haloperidol and clozapine using various behavioral tests in rats and mice and blood pressure measurements in rats. All compounds inhibited apomorphine-induced locomotor activity in rats, apomorphine-induced climbing behavior in mice and 5-hydroxyltryptophan-induced head twitches in mice and induced catalepsy in rats and in mice. LEK-8829 and clozapine, but not LEK-8841 and haloperidol, showed a certain degree of mesolimbic selectivity, i.e. they caused more potent ihibition of apomorphine-induced locomotion compared with the induction of catalepsy in rats. In the case of LEK-8829, nonspecific effects that presumably predict side effect profile, such as potentiation of pentobarbital-induced anesthesia in mice (sedation), antagonism of oxotremorine-induced tremor in mice (anticholinergic activity), spontaneous locomotor activity in mice, and noradrenaline-induced lethality in rats (sedation and hypotension), were relatively weak compared with the activities described earlier. In contrast, LEK-8841 showed nonspecific effects at the similar dose levels as dopamine antagonistic and 5-HT antagonistic effects. The results of direct measurements of the influences of both compounds on blood pressure agreed with the previously mentioned findings, i.e. LEK-8829 was relatively less Abstract truncated at 3200 characters. | |
Deskriptorji | CATALEPSY BEHAVIOR, ANIMAL ERGOLINES BLOOD PRESSURE ANIMALS, LABORATORY MICE RATS HALOPERIDOL CLOZAPINE |